CAS 19685-09-7: Hydroxycamptothecin
Description:Hydroxycamptothecin is a potent alkaloid derived from the plant Camptotheca acuminata, known for its anticancer properties. It belongs to the class of compounds called camptothecins, which are characterized by their ability to inhibit the enzyme topoisomerase I, leading to DNA damage and apoptosis in cancer cells. Hydroxycamptothecin exhibits a unique structure featuring a pentacyclic ring system, which is crucial for its biological activity. This compound is typically soluble in organic solvents and has limited solubility in water, which can pose challenges for formulation in pharmaceutical applications. Its therapeutic potential has been explored in various cancer types, including colorectal and ovarian cancers. However, its clinical use is often limited by issues such as toxicity and stability. Research continues to focus on improving its pharmacological profile and developing derivatives that enhance its efficacy and reduce side effects. Overall, Hydroxycamptothecin represents a significant compound in the field of cancer therapeutics, with ongoing studies aimed at optimizing its use in clinical settings.
Formula:C20H16N2O5
InChI:InChI=1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1
InChI key:InChIKey=HAWSQZCWOQZXHI-FQEVSTJZSA-N
SMILES:O=C1OCC=2C(=O)N3C(=CC2C1(O)CC)C=4N=C5C=CC(O)=CC5=CC4C3
- Synonyms:
- (+/-)-4-Ethyl-4,9-Dihydroxy-1H-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinoline-3,14(4H,12H)-Dione
- (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 10-Hcpt
- 10-Hydroxy Camptothecin
- 10-Hydroxycamptothecin
- 10-Hydroxycamptothecine
- 10Hydroxy Camptothecin
- 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-
- 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-
- See more synonyms
- 7-Ethy Hydroxycamptothecin
- Camptothecine, 10-hydroxy-
- ChEMBL 273862
- Hydroxy camptothecine
- Hydroxycamptothecin
- NSC 107124

10-Hydroxycamptothecin
Ref: 3B-H1463
1g | 177.00 € |

Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
Ref: 45-1347610
10mg | 1,477.00 € |

(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Ref: IN-DA0032GC
1g | 47.00 € | ||
5g | 126.00 € | ||
25g | 599.00 € | ||
100mg | 25.00 € | ||
250mg | 25.00 € | ||
500mg | 42.00 € |

Irinotecan EP Impurity B (Irinotecan USP Related Compound A, 10-Hydroxy Camptothecin)
Ref: 4Z-I-1838
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

Ref: 54-OR1008613
1g | 82.00 € | ||
5g | 196.00 € | ||
25g | 496.00 € | ||
100g | 1,754.00 € | ||
250mg | 32.00 € |

Ref: BP-BP0014
20mg | 24.00 € | ||
100mg | 40.00 € | ||
1000mg | 88.00 € |

(S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ((S)-10-Hydroxycamptothecin)
Controlled ProductRef: 86-MM1157.02-0025
25mg | 614.00 € |

(S)-10-Hydroxycamptothecin
- Inhibitors
- Apoptosis
- p53
- c-Myc
- See more categories
- Topoisomerase
Ref: TM-T2764
25mg | 52.00 € | ||
50mg | 66.00 € | ||
100mg | 92.00 € | ||
500mg | 187.00 € | ||
1mL*10mM (DMSO) | 63.00 € |

10-Hydroxy Camptothecin
Controlled ProductRef: TR-H875000
1mg | 120.00 € | ||
10mg | 177.00 € | ||
100mg | 772.00 € |

10-Hydroxycamptothecin
Ref: 3D-FH16009
1g | 333.00 € | ||
2g | 483.00 € | ||
5g | 650.00 € | ||
250mg | 222.00 € | ||
500mg | 267.00 € |